MARPAI, INC. HIRES PHARMACY EXECUTIVE MIMI DAVIS AS PRESIDENT OF MARPAIRX TO DRIVE STRATEGIC GROWTH
Rhea-AI Summary
Marpai (OTCQX: MRAI) announced the hire of Mimi Davis as President of MarpaiRx on January 27, 2026. Davis joins from Knipper Health, bringing prior leadership at Eagle Pharmacy and extensive experience in Pharmacy Benefit Management and retail pharmacy operations. She will oversee strategic expansion, operational scaling, and efforts to streamline pharmacy operations while enhancing MarpaiRx's value proposition. Management says Davis will support growth and integration of Marpai's technology and clinical insights to deliver cost-effective pharmacy benefits to members and clients.
Positive
- Appointed Mimi Davis as President of MarpaiRx on January 27, 2026
- Davis brings PBM and retail pharmacy leadership from Knipper Health and Eagle Pharmacy
- Mandate to scale operations and enhance MarpaiRx value proposition
Negative
- None.
News Market Reaction – MRAI
In the Jan 27 session, MRAI declined 6.14%, reflecting a notable negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Davis joins Marpai from Knipper Health, where she served as Executive Vice President of Operations. Her deep industry roots include a significant tenure at Eagle Pharmacy—a former HillCour portfolio company—which was acquired by Knipper in 2020. With a career spanning leadership roles in Pharmacy Benefit Management (PBM) and retail pharmacy operations, Davis brings a rare blend of operational rigor and innovative vision to the Marpai leadership team.
"MarpaiRx is at a pivotal inflection point, and we needed a leader who not only understands the complexities of the pharmacy landscape but knows how to scale rapidly without sacrificing excellence," said Damien Lamendola, CEO of Marpai. "Mimi's track record in both large-scale operations and high-growth environments is unmatched. Her expertise will be a tremendous asset as we support the tremendous growth of MarpaiRx and continue to deliver innovative, cost-saving Rx solutions to our members and clients."
The appointment comes as Marpai continues to disrupt the traditional TPA model by integrating advanced technology with deep clinical insights driving down the cost of healthcare benefits. Davis will be responsible for enhancing MarpaiRx's value proposition, streamlining pharmacy operations, and ensuring the delivery of high-touch, cost-effective pharmacy benefits.
"I am thrilled to join Marpai at such an exciting time in the company's evolution," said Mimi Davis. "The intersection of pharmacy operations and Marpai's data analytics platform presents a unique opportunity to redefine how pharmacy benefits are delivered. I look forward to leading the MarpaiRx team as we enter this next chapter of innovation and growth."
About Marpai, Inc.
Marpai, Inc. (OTCQX: MRAI) is a technology platform company which operates subsidiaries that provide TPA, PBM and value-oriented health plan services to employers that directly pay for employee health benefits. Primarily competing in the
Forward-Looking Statement Disclaimer
This press release contains forward-looking statements, as that term is defined in the Private Litigation Reform Act of 1995, that involve significant risks and uncertainties. Forward-looking statements can be identified through the use of words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," "guidance," "may," "can," "could", "will", "potential", "should," "goal" and variations of these words or similar expressions. For example, the Company is using forward-looking statements when it discusses advanced technology with deep clinical insights driving down the cost of healthcare benefits. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect Marpai's current expectations and speak only as of the date of this release. Actual results may differ materially from Marpai's current expectations depending upon a number of factors. These factors include, among others, adverse changes in general economic and market conditions, competitive factors including but not limited to pricing pressures and new product introductions, uncertainty of customer acceptance of new product offerings and market changes, risks associated with managing the growth of the business. Except as required by law, Marpai does not undertake any responsibility to revise or update any forward-looking statements whether as a result of new information, future events or otherwise.
More detailed information about Marpai and the risk factors that may affect the realization of forward-looking statements is set forth in Marpai's filings with the Securities and Exchange Commission. Investors and security holders are urged to read these documents free of charge on the SEC's web site at http://www.sec.gov.
View original content to download multimedia:https://www.prnewswire.com/news-releases/marpai-inc-hires-pharmacy-executive-mimi-davis-as-president-of-marpairx-to-drive-strategic-growth-302671235.html
SOURCE Marpai